2025-01-26 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO):**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments.

The cumulative return of ISRG (325.95%) significantly outperforms the S&P 500 (VOO) cumulative return (52.12%).  The difference in returns is 273.8%, placing it at the 91.6th percentile of its historical range compared to the S&P 500.  This indicates a substantial outperformance relative to the broader market.  The provided Alpha values consistently exceed 1.0, further supporting this conclusion.

**Alpha and Beta Analysis:**

The provided Alpha and Beta values reveal that ISRG consistently outperforms the market (Alpha > 1.0) while demonstrating a beta of approximately 1.0, suggesting its price movements correlate strongly with the overall market.  However, the high Alpha values across different periods emphasize that ISRGâ€™s returns significantly surpass market benchmarks.  The increasing CAGR (Compound Annual Growth Rate) values across the provided periods suggest accelerating growth.  The relatively low Maximum Drawdown (MDD) in recent periods shows the stock's resilience despite market fluctuations.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2020-2022  | 43.0% | 20.6% | 44.0% | 1.0 | 94.5 |
| 2021-2023  | 19.0% | 20.6% | 10.0% | 1.0 | 120.2 |
| 2022-2024  | 128.0% | 20.4% | 105.0% | 1.0 | 185.9 |
| 2023-2025  | 220.0% | 9.9% | 177.0% | 1.0 | 208.0 |


**2. Recent Price Movement:**

* **Closing Price:** $584.05
* **Previous Close:** $608.66
* **5-Day Moving Average:** $599.98
* **20-Day Moving Average:** $556.37
* **60-Day Moving Average:** $540.82

The stock price shows a recent decline, currently trading below its 5-day, 20-day, and 60-day moving averages, indicating a bearish short-term trend.


**3. Technical Indicators & Expected Return:**

* **RSI:** 69.88 (Approaching overbought territory)
* **PPO:** 0.99 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence Change:** -8.4% (Short-term downward trend)

The RSI nearing 70 suggests the stock may be overbought, potentially indicating a short-term correction is possible.  The positive PPO confirms some bullish momentum, but the negative divergence change suggests a weakening short-term upward trend.  The recent price drop (-4.04%) reflects a short-term negative market reaction, but it doesn't necessarily negate the long-term positive outlook. The expected return of 35.2% over the long term (2+ years) relative to the S&P 500 is significant.


**4. Recent Earnings Analysis:**

The earnings data shows a generally increasing trend in both EPS and Revenue, although there's some fluctuation.  Note the duplicated entry for 2024-10-18.  This inconsistency requires clarification from the original data source.


| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-18 | 1.59 | $2.04 B       |
| 2024-07-19 | 1.48 | $2.01 B       |
| 2024-04-19 | 1.54 | $1.89 B       |
| 2023-10-20 | 1.18 | $1.74 B       |
| 2024-10-18 | 1.18 | $1.74 B       |


**5. Financial Information:**

**Revenue and Profitability:** Revenue has shown a generally upward trend,  with consistent high profit margins above 65%.


| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-09-30  | $2.04B   | 67.41%        |
| 2024-06-30  | $2.01B   | 68.30%        |
| 2024-03-31  | $1.89B   | 65.87%        |
| 2023-12-31  | $1.93B   | 66.24%        |
| 2023-09-30  | $1.74B   | 66.94%        |

**Capital and Profitability:** Equity is steadily increasing, however, ROE (Return on Equity) shows some fluctuation. Further analysis is needed to understand the drivers behind these fluctuations.


| Quarter     | Equity    | ROE   |
|-------------|-----------|-------|
| 2024-09-30  | $15.58B   | 3.63% |
| 2024-06-30  | $14.71B   | 3.58% |
| 2024-03-31  | $13.96B   | 3.90% |
| 2023-12-31  | $13.31B   | 4.56% |
| 2023-09-30  | $12.54B   | 3.32% |


**7. Overall Summary:**

ISRG demonstrates strong long-term growth potential, significantly outperforming the S&P 500.  While short-term indicators suggest a potential correction, the fundamental financial strength (high profit margins, increasing revenue, and high Alpha), coupled with the long-term expected return, paints a positive picture for long-term investors.  However, the inconsistencies in the earnings data need to be addressed.  Investors should monitor the RSI and price action for potential short-term volatility, but the long-term outlook remains bullish.  Further investigation into the ROE fluctuations and clarification of the duplicated earnings data points are recommended before making any investment decisions.
